About Bridgetech Holdings International, Inc.
Bridgetech is leveraging its extensive network of relationships in China and the U.S. to capitalize on the demand for Western healthcare in Greater China. The company is bringing emerging drugs, devices and diagnostics to Greater China, with an initial focus on oncology. For additional information, please visit Bridgetech at http://www.bthi.com.
About the Agency for Healthcare Research and Quality
The mission of the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services, is to improve the quality, safety, efficiency, and effectiveness of health care. AHRQ fulfills its mission through establishing a broad base of scientific research to promote improvements in clinical and health system practices, including the prevention of diseases and other health conditions. On a daily basis, this means ensuring that providers use evidence-based research to deliver high-quality health care and to work with their patients as partners. For additional information, please visit AHRQ at http://www.ahrq.gov.
Statements contained in this press release that are not statements of
historical fact are "forward-looking statements" as that term is defined
under federal securities laws, including, without limitation, all
statements concerning expectations, beliefs, goals, intention or strategies
for the future of Bridgetech. Forward-looking statements may be identified
by words such as "goals," "plans," "believes," "will," "expects" and other
words of similar meaning used in conjunction with, among other things,
discussions of future operations, financial performance, product
development and new ventures. Many factors could cause actual events or
results to differ materially from those expressed in any forward-looking
statement. Investors are caution
|SOURCE Bridgetech Holdings International Inc.|
Copyright©2007 PR Newswire.
All rights reserved